Hong Kong
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.69 B
|
Dec. 31, 2023 | USD 0.37 | 1.03% |
|
Hong Kong |
|
2 |
USD 2.46 B
|
Dec. 31, 2023 | USD 14.74 | 7.67% |
|
Hong Kong |
|
3 |
USD 838.00 M
|
Dec. 31, 2023 | USD 3.02 | 2.59% |
|
Hong Kong |
|
4 |
USD 259.86 M
|
Dec. 31, 2023 | USD 0.21 | 8.82% |
|
Hong Kong |
|
5 |
USD 155.56 M
|
Dec. 31, 2023 | USD 0.83 | 3.07% |
|
Hong Kong |
|
6 |
USD 43.77 M
|
Dec. 31, 2023 | USD 0.10 | 0.02% |
|
Hong Kong |
|
7 |
USD 21.74 M
|
Dec. 31, 2023 | USD 5.81 | -1.19% |
|
Hong Kong |
|
8 |
USD 10.64 M
|
Dec. 31, 2023 | USD 0.26 | 2.03% |
|
Hong Kong |
|
9 |
USD 397.00 K
|
Dec. 31, 2023 | USD 0.39 | 0.30% |
|
Hong Kong |
|
10 |
USD 192.26 K
|
Dec. 31, 2023 | USD 0.13 | -1.02% |
|
Hong Kong |
|
11 |
USD 0.00
|
June 30, 2024 | USD 4.86 | -4.71% |
|
Hong Kong |
The Biotechnology company in Hong Kong with the highest Revenue is Sino Biopharmaceutical Limited (HKSE: 1177.HK) at USD 3.69 B.
The Biotechnology company in Hong Kong with the lowest Revenue is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD 0.00.
The top 10 Biotechnology companies in Hong Kong by Revenue are Sino Biopharmaceutical Limited, BeiGene, Ltd., HUTCHMED (China) Limited, Frontage Holdings Corporation, Guangdong Hybribio Biotech Co.,Ltd., Yunnan Energy International Co. Limited, Prenetics Global Limited, KuangChi Science Limited, Sirnaomics Ltd. and SinoMab BioScience Limited.
The bottom 10 Biotechnology companies in Hong Kong by Revenue are Regencell Bioscience Holdings Limited, SinoMab BioScience Limited, Sirnaomics Ltd., KuangChi Science Limited, Prenetics Global Limited, Yunnan Energy International Co. Limited, Guangdong Hybribio Biotech Co.,Ltd., Frontage Holdings Corporation, HUTCHMED (China) Limited and BeiGene, Ltd..